| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 11/06/2008 | US20080274991 Nucleic Acids Against Viruses, in Particular Hiv |
| 11/06/2008 | US20080274987 Novel alpha glucosidase activator, pulicarside 1 |
| 11/06/2008 | US20080274980 Macromonomers and hydrogel systems using native chemical ligation, and their methods of preparation |
| 11/06/2008 | US20080274972 T-cell epitope peptides |
| 11/06/2008 | US20080274960 Fibrosis Inhibitor for Implanted Organ |
| 11/06/2008 | US20080274948 Conjugates of Hydroxyalkyl Starch and G-Csf |
| 11/06/2008 | US20080274506 Host cell comprising vector expressing protein fusion comprising neonatal Fc receptor for use in enhancing antibody-dependent cell-mediated cytotoxicity (ADCC) targeting of cancer cells |
| 11/06/2008 | US20080274498 Transgenic methylotrophic yeast for use as bioreactors in production of heterologous polypeptides |
| 11/06/2008 | US20080274490 Using protein tyrosine phosphatase (SHP-2) as tool in identifying compounds which modulate the activity of programed death-1 (PD-1); treating autoimmune, nervous system, tumor and immunosuppressive disorders |
| 11/06/2008 | US20080274475 Hla-e binding |
| 11/06/2008 | US20080274209 Methods of treating inflammation |
| 11/06/2008 | US20080274196 Bioequivalent to tablet dosage form; combination of compacted and plain powder; controlled particle size; bioavailability without enhancing substances |
| 11/06/2008 | US20080274144 Genetically engineered or synthetically produced HCV (hepatitis C virus) E1 envelope proteins or parts thereof comprising disulfides between specific cysteine residues; viral-like particles; biodrugs |
| 11/06/2008 | US20080274141 Animal cells and processes for the replication of influenza viruses |
| 11/06/2008 | US20080274136 Polyvalent Attenuated Live Vaccine For Preventing and Curing Vibriosis of Cultivated Fish |
| 11/06/2008 | US20080274132 Vaccines for blocking transmission of plasmodium vivax |
| 11/06/2008 | US20080274131 Molecular antigen arrary |
| 11/06/2008 | US20080274126 Oral Vaccines for Fish |
| 11/06/2008 | US20080274125 Human Stem Cell Lines Derived From Es Cells and Uses for Production of Vaccines and Recombinant Proteins |
| 11/06/2008 | US20080274118 CD40 specific immunoglobulin for prevention and treatment of arthritic, cardiovascular, allergic, neurodegenerative and/or blood disorders |
| 11/06/2008 | US20080274110 Minibodies for use in treatment and prevention of cell proliferative and/or autoimmune disorders |
| 11/06/2008 | US20080274105 Polypeptide variants with altered effector function |
| 11/06/2008 | US20080274102 Antibodies to Nik, Their Preparation and Use |
| 11/06/2008 | US20080274091 Using lentiviral vector to transduce hematopoietic system and/or hematopoietic stem cells; improving heterologous gene expression; gene and tissue targeted therapies |
| 11/06/2008 | US20080274085 Nutrient broth comprising bifidobacterium for use as therapeutic in treatment of gastrointestinal disorders |
| 11/06/2008 | US20080274059 Mite fusion proteins |
| 11/06/2008 | US20080274047 producing antibodies which bind NK cell receptors for use in therapeutic strategies for treating immunoproliferative and autoimmune disorders |
| 11/06/2008 | DE102007020254A1 Use of an agent reducing the bioavailability of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to prepare a medicament, especially for treating allergic diseases |
| 11/06/2008 | CA2685136A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 11/06/2008 | CA2685124A1 Products for altering il-33 activity and methods therefor |
| 11/06/2008 | CA2685015A1 Anti-mdl-1 antibodies |
| 11/06/2008 | CA2684968A1 Compounds, compositions containing such compounds, and methods of treatment of cancer and autoimmune diseases using such compounds |
| 11/06/2008 | CA2683145A1 Antagonists to il-17a, il-17f, and il-23p19 and methods of use |
| 11/06/2008 | CA2682889A1 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 11/05/2008 | EP1988097A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 11/05/2008 | EP1987823A1 Condensation aerosol containing zaleplon for inhalation |
| 11/05/2008 | EP1987064A1 Domain antibody construct |
| 11/05/2008 | EP1987061A1 Soluble receptors and methods for treating autoimmune or demyelinating diseases |
| 11/05/2008 | EP1986688A2 Methods of using antibodies against human il-22 |
| 11/05/2008 | EP1986621A1 Use of resveratrol and derivatives thereof for promoting the wellness state in mammals |
| 11/05/2008 | EP1597258B1 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use |
| 11/05/2008 | EP1465996B1 Raf/ras binding compounds |
| 11/05/2008 | EP1448215B1 Use of laminarin in the treatment of cancer |
| 11/05/2008 | EP1363937B1 Immunomodulating agents from parasitic worms and method for isolation thereof |
| 11/05/2008 | EP1341811B9 Orally ingestible preparation of mistletoe lectins and method |
| 11/05/2008 | EP1309544B1 Compounds acting as melanocortin receptor ligands |
| 11/05/2008 | EP1296973B1 Guanidine derivatives of quinazoline for use in the treatment of autoimmune diseases |
| 11/05/2008 | EP1216247B1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 11/05/2008 | EP1196193B1 Interleukin-1 mutein useful as vaccine adjuvant |
| 11/05/2008 | EP0912601B2 Suppression of immune response via inhibition of cathepsin s |
| 11/05/2008 | CN101300341A Lactic acid bacterium having immunoregulatory activity derived from moromi for wine fermentation |
| 11/05/2008 | CN101300272A Compositions and methods for treating proliferative disorders |
| 11/05/2008 | CN101300259A Tricyclic spiro derivatives as CRTH2 modulators |
| 11/05/2008 | CN101298481A Inhibitors of complement activation |
| 11/05/2008 | CN101298478A Method for detecting and purifying CD8+T lymphocyte populations, specific of peptides present in context of hla |
| 11/05/2008 | CN101298471A Epitope capable of exciting human body anti-mycobacterium tuberculosis protective immunity reaction and use thereof |
| 11/05/2008 | CN101297968A Preparation of pig serum immunoglobulin microsphere novel dosage form |
| 11/05/2008 | CN101297964A Preparation of chicken thymosin microsphere novel dosage form |
| 11/05/2008 | CN101297959A Preparation of chicken interleukin-2 microsphere novel dosage form |
| 11/05/2008 | CN101297902A Dietary cure cool paste formulation for transforming hepatitis B í«great three positiveí» into negative and improving immunity |
| 11/05/2008 | CN101297888A Medicament composition and preparation thereof |
| 11/05/2008 | CN101297818A Animal sperm medicinal materials and uses thereof in medicaments for curing tumor, depression and multiple diseases |
| 11/05/2008 | CN101297815A Powder combined with Chinese medicament and western medicament for improving immunity of chicken and preparation thereof |
| 11/05/2008 | CN101297810A Uses of Arctium lappa oligofructose in medicament or health care food |
| 11/05/2008 | CN101297796A Grifola frondosa beta-dextran freeze-dried powder for injection |
| 11/05/2008 | CN101297672A Method for producing active peptides from enzymolysis of fish proteins using active enzymes in angleworm intestinal canal |
| 11/05/2008 | CN101297667A Dandelion health-care tea and preparing process thereof |
| 11/05/2008 | CN100430478C CASB618 polynucleotides and polypeptides and their use |
| 11/05/2008 | CN100430419C Anti-CD40 monoclonal antibody |
| 11/05/2008 | CN100430418C Method of preparing monoclonal antibody, monoclonal antibody, pharmaceutical composition and diagnostic reagent |
| 11/05/2008 | CN100430082C Glossy ganoderma spore essential oil compound capsules and preparation thereof |
| 11/05/2008 | CN100430048C Alpha-2-delta ligand to treat lower urinary tract symptoms |
| 11/05/2008 | CN100430045C Radix bupleuri dripping pill and its preparing method |
| 11/05/2008 | CN100429996C Antifatigue health product improving human body immunity function effectively and preparing method thereof |
| 11/04/2008 | US7446222 2-benzyloxy-5-chloro-[1,1';2',1'']terphenyl-3''-carboxylic acid; neuropathic pain; chronic articular pain (e.g. rheumatoid arthritis, osteoarthritis, rheumatoid spondylitis, gouty arthritis and juvenile arthritis) including the property of disease modification and joint structure preservation |
| 11/04/2008 | US7446189 Use as vaccine adjuvants; useful in the treatment of autoimmune diseases and immunosuppression |
| 11/04/2008 | US7446183 Fusion protein comprising growth hormone and growth hormone receptor |
| 11/04/2008 | US7446179 CD19-specific chimeric T cell receptor |
| 11/04/2008 | US7446175 Antibodies to human IL-1β |
| 11/04/2008 | US7446173 amino acid sequence coupled to a non-naturally-occurring polyoxyalkylene glycol at N-terminal end of glycosylated interferon-beta-1a through a coupling group such as aldehyde, maleimide, a vinylsulfone,or haloacetate groups; enhanced activity; Multiple sclerosis; cancer; therapeutical; water solubility |
| 11/04/2008 | US7446111 Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions |
| 11/04/2008 | US7446105 4-(1,2-diethyl-4-methylimidazol-5-yl)-2-{4-[N-(2-methoxyethyl)sulphamoyl]anilino}pyrimidine; selectivity for cyclin-dependent serine/threonine kinases (CDK2, CDK4 and CDK6); antiproliferative agent; minimize pharma toxicity on S-phase cell cycle, G2 or mitosis; oncogene signalling pathways |
| 11/04/2008 | US7446097 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 11/04/2008 | US7446095 Peptides modulating caspase activation |
| 11/04/2008 | US7445903 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
| 11/04/2008 | US7445781 Inhibits B-cell activation by binding to protein receptor on helper T-cell membrane; treatment of allergy or autoimmune disease |
| 11/04/2008 | US7445780 Antagonistic anti-CD40 antibodies |
| 11/04/2008 | US7445768 Delivery of sedative-hypnotics through an inhalation route |
| 11/04/2008 | US7445764 Carrier-drug conjugate |
| 11/04/2008 | CA2443449C Pyrazole derivatives for treating hiv |
| 11/04/2008 | CA2136870C Anti-aids immunomodulation complex |
| 10/30/2008 | WO2008131242A1 Single chain fc, methods of making and methods of treatment |
| 10/30/2008 | WO2008131006A2 Method for inhibiting scavenger receptor-a and increasing immune response to antigens |
| 10/30/2008 | WO2008130953A2 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands |
| 10/30/2008 | WO2008130172A1 N- hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same |
| 10/30/2008 | WO2008129996A1 Composition against atopic disease |
| 10/30/2008 | WO2008129994A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 10/30/2008 | WO2008129841A1 Composition comprising lactic acid bacterium having high anti-allergic activity, and method for production of the lactic acid bacterium |
| 10/30/2008 | WO2008129624A1 Pyrazolopyridine-4-yl-pyrazolone derivative, addition salt thereof and phosphodiesterase inhibitor containing the same as active ingredient |
| 10/30/2008 | WO2008129103A1 Use of african swine pest haemoglutinin as an adjuvant |